Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 447

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 2
Chunk 447
---
 diplomat stationed in Europe.
Dr. Zhang currently sits on the board of China Oxford Scholarship Fund and is involved in the process for scholarship awardee selection
every year. Dr. Zhang holds a Ph.D. degree from China University of International Business and Economics, Master degrees from both Peking
University (LL.M.) and Oxford University (Magister Juris), and a B.A. degree from Shanghai Institute of Foreign Trade.

Number
and Terms of Office of Officers and Directors

Our
Board of Directors consists of seven members. Holders of our Founder Shares have the right to appoint all of our directors prior to consummation
of our initial Business Combination and holders of our Public Shares do not have the right to vote on the appointment of directors during
such time. These provisions of our Articles may only be amended by a special resolution passed by at least 90% of our ordinary shares
voting in a general meeting. Each of our directors holds office for a two-year term. Subject to any other special rights applicable to
the shareholders, any vacancies on our Board of Directors may be filled by the affirmative vote of a majority of the directors present
and voting at the meeting of our Board of Directors or by a majority of the holders of our Founder Shares.

Our
officers are appointed by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms
of office. Our Board of Directors is authorized to appoint persons to the offices set forth in our Articles as it deems appropriate.
Our Articles provides that our officers may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Vice
Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by the Board of Directors.

Director
Independence

Our securities were listed on Nasdaq until March 11, 2025, and we continue to follow Nasdaq’s listing standards
with regard to director independence and board committee composition. The
rules of Nasdaq require that a majority of our Board of Directors be independent within one year of our IPO. An “independent director”
is defined generally as a person who, in the opinion of the company’s board of directors, has no material relationship with the
listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company).
Our Board of Directors has determined that Dr. Joong Myung Cho, John Kim, Young Min Kim, Gary Wunderlich, and Dr. Zhe